Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-29 5:26 pm Purchase | 2024-10-22 | 13D | Opus Genetics, Inc. IRD | Foundation Fighting Blindness Retinal Degeneration Fund | 2,564,752 8.160% | 2,564,752 (New Position) | Filing History |
| 2023-02-14 3:23 pm Sale | 2022-12-31 | 13G | Opus Genetics, Inc. IRD | Sooch Mina | 1,187,352 5.500% | -98,910 (-7.69%) | Filing History |
| 2022-05-17 4:37 pm Purchase | 2022-04-12 | 13G | Opus Genetics, Inc. IRD | Richmond Brothers Inc. | 1,193,633 6.200% | 776,219 (+185.96%) | Filing History |
| 2022-02-14 4:10 pm Unchanged | 2021-12-31 | 13G | Opus Genetics, Inc. IRD | Sooch Mina | 1,286,262 6.700% | 0 (Unchanged) | Filing History |
| 2022-02-14 09:53 am Unchanged | 2021-12-31 | 13G | Opus Genetics, Inc. IRD | Altium Capital Management LLC | 2,678,883 4.990% | 0 (Unchanged) | Filing History |
| 2022-01-18 11:17 am Purchase | 2021-12-31 | 13G | Opus Genetics, Inc. IRD | Empery Asset Management LP | 3,063,498 4.990% | 384,615 (+14.36%) | Filing History |
| 2021-03-26 4:05 pm Purchase | 2020-11-06 | 13G | Opus Genetics, Inc. IRD | Apexian Pharmaceuticals Inc. | 779,993 7.136% | 779,993 (New Position) | Filing History |
| 2021-03-16 7:58 pm Purchase | 2020-12-31 | 13G | Opus Genetics, Inc. IRD | Sooch Mina | 1,286,262 11.800% | 1,286,262 (New Position) | Filing History |
| 2021-02-16 09:17 am Purchase | 2020-12-31 | 13G | Opus Genetics, Inc. IRD | Altium Capital Management LLC | 2,678,883 9.990% | 2,087,867 (+353.27%) | Filing History |
| 2021-02-02 10:26 am Purchase | 2020-12-31 | 13G | Opus Genetics, Inc. IRD | Empery Asset Management LP | 2,678,883 9.990% | 2,087,867 (+353.27%) | Filing History |
| 2020-11-16 2:21 pm Purchase | 2020-11-06 | 13G | Opus Genetics, Inc. IRD | Richmond Brothers Inc. | 417,414 5.800% | 417,414 (New Position) | Filing History |
| 2020-11-16 2:00 pm Purchase | 2020-11-05 | 13G | Opus Genetics, Inc. IRD | Altium Capital Management LLC | 591,016 8.300% | 591,016 (New Position) | Filing History |
| 2020-11-12 10:38 am Purchase | 2020-11-05 | 13G | Opus Genetics, Inc. IRD | Empery Asset Management LP | 591,016 8.330% | 591,016 (New Position) | Filing History |
| 2020-08-10 5:02 pm Purchase | 2020-07-31 | 13G | REXAHN PHARMACEUTICALS INC REXN | Armistice Capital, LLC | 44,145 1.000% | 44,145 (New Position) | Filing History |